Register entry

X4 Pharmaceuticals, Inc.

Data as of · How to read this entry

Registered sites
0
Active NDC listings
1
Live patents
6
Exclusivities
1
Countries
0
Exclusivity

Patents and exclusivities

6
PatentProductCoversExpiry
10953003XOLREMDImavorixaforproductDec 2036
10610527XOLREMDImavorixaforuseDec 2036
11219621XOLREMDImavorixaforuseDec 2036
10548889XOLREMDImavorixaforproductDec 2038
11045461XOLREMDImavorixaforproductDec 2038
12115156XOLREMDImavorixaforproductDec 2038
ProductExclusivityUntil
XOLREMDIMAVORIXAFORODE-480 Orphan drugApr 2031
Catalogue

Marketed products

1
BrandGeneric nameForm / routeNDC
XOLREMDImavorixaforcapsule, gelatin coated, oral83296-100NDA
Enquiry

Common questions

Is X4 Pharmaceuticals, Inc. FDA approved?
X4 Pharmaceuticals, Inc. holds no registered establishment of its own; 1 drug product is listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does X4 Pharmaceuticals, Inc. make?
1 product is listed under X4 Pharmaceuticals, Inc. in the openFDA NDC Directory, most often as capsule, gelatin coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.